150+ founders supported · £10m+ in non-dilutive funding · 80% grant success rate

A presenter pointing to financial charts on a screen in a boardroom
For Investors

Reduce commercial risk across your portfolio.

For VCs, angels and corporate venture funds backing technical founders pre-Series A, we act as the commercial team behind your technical founders, de-risking go-to-market and strengthening your portfolio.

Applied AI Health & Life Sciences Deep Tech ClimateTech

At pre-seed and seed, finding product-market fit is key: who’ll pay, what they’ll pay, why they’d switch. The commercial evidence to back these up is often the hardest part for founders.

We support your due diligence with commercial evidence, work alongside portfolio founders to build commercial cases, and write UK grants that extend runway.

Where we work

Over a decade of experience in these sectors

01
Applied AI

B2B AI software

FinTech · RegTech · Mobility · Productivity · PropTech · Retail · CreaTech

Programmes & Organisations

Amazon Innovation Accelerator · Growth Studio · Cranfield · TechUp · CoSTAR · Durham University · Help To Grow

02
Health & Life Sciences

From clinical to consumer

Clinical Diagnostics · Wearables · Fitness & Wellness · Consumer Health

Programmes & Organisations

NHS Leadership Academy · NHS Blood and Transplant · Versus Arthritis · De Montfort University · Cambridge NHS Trust · Islington Council · Health Foundation

03
Deep Tech & ClimateTech

Deep science & hard tech

Engineering Biology · Biomaterials · Net-Zero · Recycled Materials · AgriTech

Programmes & Organisations

Undaunted · Carbon13 · Amazon Sustainability Accelerator · APC Mobilise · Silicon Roundabout · Cranfield University · Science Creates

How we work with funds

De-risking your portfolio

01 Before you invest

Commercial due diligence

Independent assessment of pipeline companies. We evaluate the commercial evidence behind the pitch deck: who’ll pay, what they’ll pay, why they’d switch. Useful for SEIS/EIS-stage diligence and follow-on decisions.

Funds wanting independent commercial signals before writing the cheque.
02 After you commit funding

Portfolio companies support

Investor-funded sprints, 1:1 founder clinics, and grant writing for your portfolio companies. We do the commercial work alongside founders, strengthening your portfolio through evidence-led decisions.

Funds wanting their portfolio companies commercially sharper without their internal team having to deliver it.
03 Across your portfolio

Strategic partnership

Long-term commercial partnership across your portfolio. Cohort training on customer discovery and grants, periodic PMF reviews across companies, and cross-portfolio commercial insights.

Funds wanting a long-term commercial partner across their portfolio.
How we can work together

Our services

01

Investor-funded sprints

Two to four week commercial validation sprints delivered to your portfolio companies, paid by the fund.

  • Market Validation
  • Demand Validation
  • Go-to-market
  • MVP
Best for funds whose portfolio companies need commercial work the founder won’t fund.
02

Grant writing

UK grant applications written for portfolio companies. 80% success rate against the Innovate UK average of 25%.

  • Innovate UK
  • Scottish Enterprise
  • Sovereign AI
Best for funds wanting non-dilutive capital flowing into the portfolio.
03

1:1 founder clinics

Structured one-to-one sessions with founders in your portfolio. We assess their commercial evidence, identify the gap, and give them a clear next step.

Best for funds whose founders need a sharp commercial reset, not a full engagement.
04

Due diligence support

We back your commercial due diligence with independent assessment of pipeline companies. The evidence behind the pitch deck.

  • Pre-investment signals
  • Follow-on decisions
  • SEIS/EIS-stage
Best for funds making investment or follow-on decisions.
Learn at your own pace

Our products

Make Products That Matter, book cover
Book

A practical guide for learning customer and user needs throughout the product lifecycle, from idea to launch.

Get the book →
Online courses
Online courses

Grant Funding Fundamentals for founders new to grants. Design Thinking for Deep Tech to get customer insights from the start.

Juno, AI customer discovery assistant
AI Assistant: Juno

Juno is your guide to understanding your customer, the market and competition landscape, how to speak to customers and develop insights.

Learn more →
Theia, AI demand validation assistant
AI Assistant: Theia

Theia is a demand validation guide that tests where you find customers and if they’ll pay, tailored to your GTM approach.

Learn more →

Who you’ll work with

I’m Dr Chloe Sharp

Sharp Insights was started because too many technically brilliant companies were getting stuck at the same point: a working prototype that couldn’t turn into a sustainable business. The tech was the easier part. The commercial evidence was where the value got lost.

I provide independent commercial validation for early-stage investors: due diligence support, portfolio commercial work, and UK grant strategy. I work with VCs, angels and corporate ventures backing technical founders pre-Series A.

Active Innovate UK assessor. PhD in psychology, behavioural science and sociology. Angel investor. Author of Make Products That Matter.

LinkedIn profile →
Dr Chloe Sharp
From grants to growth

Selected work

It’s rare that you come across a standout talent like Chloe. I had the pleasure of working with her in the London startup ecosystem through joint projects. I was particularly impressed by Chloe’s capacity to deliver expert advice and get people on board with ideas. I’d recommend her and her company without a doubt.
Francesco Perticarari · VC and Angel Investor
Funds and investors

Silicon Roundabout Ventures · Carbon13

Founder clinics. One-to-many training for customer discovery and grant funding.

Investor-backed founders we’ve supported

Etiq AI · Waymark Tech · Oto · Flock · Eric.ai

Commercial validation, grant strategy, and product-market-fit work across pre-seed and Seed.

Strengthen the commercial case across your portfolio.